| abstract |
A use of a bioflavonoid of formula (I) or plant extract containing same for increasing the plasma high density lipoprotein (HDL) level in a mammal, wherein, R1, R2, R3, R4, R5, R6, R7, R8 and R9 are each independently hydrogen; a hydroxy group; a C1-9 alkoxy group optionally substituted with o ne or more substituents selected from the group consisting of a hydroxy, C1-5 alkoxy, aryloxy, and phenyl group substituted with 1 to 3 substituents selected from the group consisting of a hydroxy, alkoxy, aryloxy, halogen, nitro and amide group; a C5-9 cycloalkyloxy group substituted with 1 to 3 substituents selected from the group consisting of a hydroxy, alkoxy, arylox y, halogen, nitro and amido group; a C5-9 cycloalkylcarbonyloxy group substitut ed with 1 to 3 substituents selected from the group consisting of a hydroxy, alkoxy, aryloxy, halogen, nitro and amido group; a C2-10 or C16-18 acyloxy group optionally substituted with one or more substituents selected from the group consisting of a hydroxy, C1-5 alkoxy, aryloxy, and phenyl group substituted with 1 to 3 substituents selected from the group consisting of a hydroxy, alkoxy, aryloxy, halogen and nitro group; a rutinosyl group; or a rhaminosyl group; and X is a single or double bond. |